What is a Katalyst session?

These are strategic working sessions where Owkin goes in-house with pharma teams to explore how multimodal data and agentic AI can unlock new insights, break down translational research barriers and optimize clinical trials. The goal is to apply K Pro to real-world challenges and rapidly uncover high-value opportunities. These sessions are part of longer trial periods, which last 2 weeks and are otherwise held remotely.